There is a growing prevalence of various cardiovascular diseases, such as arrhythmia and atrial fibrillation, among others. According to the Centers for Disease Control and Prevention (CDC), around 12.1 million people in the U.S. are expected to suffer from atrial fibrillation (AFib) by 2030. The pandemic has fueled a demand for solutions that aim to help cater to large patient populations. At present with the aggregating patient data from disparate sources, healthcare centers are challenged with the need to quickly comprehend and communicate continuous changes with patient data.
• Artificial pacemakers have been in use since the late 1950s and have played a pivotal role in regulating the normal function of the heart by delivering electrical impulses through electrodes in patients with a dysfunctional natural electrical conduction system.
• However, the surgery procedure is not only complicated, it involves insertion of leads inside the heart and particular care needs to be taken post the surgical procedure as lead dislodgement and erosion of the pacemaker through the skin are commonly witnessed.
• Regular follow up sessions with the surgeon to evaluate the wound healing process thus become mandatory. This analysis focuses on the gaps in the care pathway and innovation opportunities and helps to understand the current industry dynamics as well as growth opportunities in this space.
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured open discussion with our growth experts providing unparalleled industry intelligence, technology advancements, and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.
